203 related articles for article (PubMed ID: 1328686)
1. Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency.
Pyles RB; Sawtell NM; Thompson RL
J Virol; 1992 Nov; 66(11):6706-13. PubMed ID: 1328686
[TBL] [Abstract][Full Text] [Related]
2. Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716.
Robertson LM; MacLean AR; Brown SM
J Gen Virol; 1992 Apr; 73 ( Pt 4)():967-70. PubMed ID: 1321881
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system.
Pyles RB; Thompson RL
J Virol; 1994 Aug; 68(8):4963-72. PubMed ID: 8035495
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of a herpes simplex virus 1 dUTPase by a viral protein kinase, Us3, dictates viral pathogenicity in the central nervous system but not at the periphery.
Kato A; Shindo K; Maruzuru Y; Kawaguchi Y
J Virol; 2014 Mar; 88(5):2775-85. PubMed ID: 24352467
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterisation of herpes simplex virus type 1 mutants which fail to induce dUTPase activity.
Fisher FB; Preston VG
Virology; 1986 Jan; 148(1):190-7. PubMed ID: 3002029
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus-induced dUTPase: target site for antiviral chemotherapy.
Williams MV
Virology; 1988 Sep; 166(1):262-4. PubMed ID: 2842952
[TBL] [Abstract][Full Text] [Related]
7. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.
Whitley RJ; Kern ER; Chatterjee S; Chou J; Roizman B
J Clin Invest; 1993 Jun; 91(6):2837-43. PubMed ID: 8390490
[TBL] [Abstract][Full Text] [Related]
8. The US 9, 10, 11, and 12 genes of herpes simplex virus type 1 are of no importance for its neurovirulence and latency in mice.
Nishiyama Y; Kurachi R; Daikoku T; Umene K
Virology; 1993 May; 194(1):419-23. PubMed ID: 8386887
[TBL] [Abstract][Full Text] [Related]
9. Identification, transfer, and characterization of cloned herpes simplex virus invasiveness regions.
Goodman JL; Cook ML; Sederati F; Izumi K; Stevens JG
J Virol; 1989 Mar; 63(3):1153-61. PubMed ID: 2536826
[TBL] [Abstract][Full Text] [Related]
10. The weakly virulent herpes simplex virus type 1 strain KOS-63 establishes peripheral and central nervous system latency following intranasal infection of rabbits, but poorly reactivates in vivo.
Stroop WG; Banks MC
J Neuropathol Exp Neurol; 1992 Sep; 51(5):550-9. PubMed ID: 1325537
[TBL] [Abstract][Full Text] [Related]
11. Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain.
Javier RT; Izumi KM; Stevens JG
J Virol; 1988 Apr; 62(4):1381-7. PubMed ID: 2831400
[TBL] [Abstract][Full Text] [Related]
12. Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS.
Thompson RL; Cook ML; Devi-Rao GB; Wagner EK; Stevens JG
J Virol; 1986 Apr; 58(1):203-11. PubMed ID: 3005649
[TBL] [Abstract][Full Text] [Related]
13. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures.
Bolovan CA; Sawtell NM; Thompson RL
J Virol; 1994 Jan; 68(1):48-55. PubMed ID: 8254758
[TBL] [Abstract][Full Text] [Related]
14. High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation.
Perng GC; Ghiasi H; Slanina SM; Nesburn AB; Wechsler SL
J Virol; 1996 May; 70(5):2883-93. PubMed ID: 8627763
[TBL] [Abstract][Full Text] [Related]
15. Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B.
Goodman JL; Engel JP
J Virol; 1991 Apr; 65(4):1770-8. PubMed ID: 1848305
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a herpes simplex virus type 2 deoxyuridine triphosphate nucleotidohydrolase and mapping of a gene conferring type specificity for the enzyme.
Williams MV; Parris DS
Virology; 1987 Feb; 156(2):282-92. PubMed ID: 3027979
[TBL] [Abstract][Full Text] [Related]
17. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation.
Perng GC; Thompson RL; Sawtell NM; Taylor WE; Slanina SM; Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
J Virol; 1995 May; 69(5):3033-41. PubMed ID: 7707530
[TBL] [Abstract][Full Text] [Related]
18. Genetic and biological analyses of a herpes simplex virus intertypic recombinant reduced specifically for neurovirulence.
Javier RT; Thompson RL; Stevens JG
J Virol; 1987 Jun; 61(6):1978-84. PubMed ID: 3033324
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of herpes simplex virus 1 dUTPase regulates viral virulence and genome integrity by compensating for low cellular dUTPase activity in the central nervous system.
Kato A; Arii J; Koyanagi Y; Kawaguchi Y
J Virol; 2015 Jan; 89(1):241-8. PubMed ID: 25320299
[TBL] [Abstract][Full Text] [Related]
20. Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1.
Meignier B; Longnecker R; Mavromara-Nazos P; Sears AE; Roizman B
Virology; 1988 Jan; 162(1):251-4. PubMed ID: 2827384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
